61 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Novus Biologicals Competitors or Alternatives

Novus Biologicals's top competitors include Tioma Therapeutics, BioLegend and Stressmarq Biosciences.

Unlock 6 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Novus Biologicals's company profile

CEO

- -
25 - 100
$0
$5M - 25M
  • $0
    $5M - 25M
  • 25 - 100
    $0
  • $5M - 25M
  • - -
  • 25 - 100
  • $0
  • $5M - 25M
View ProfileView
1
Novus Biologicals's Competitor - Tioma Therapeutics logo

John Donovan

CEO

69/100
100 - 250
$120.4M
$100K - 5M
  • $120.4M
    $100K - 5M
  • 100 - 250
    $120.4M
  • $100K - 5M
  • 69/100
  • 100 - 250
  • $120.4M
  • $100K - 5M
View ProfileView
2
Novus Biologicals's Competitor - BioLegend logo

Gene Lay

President & CEO

72/100
500 - 1,000
- -
$100M - 500M
  • - -
    $100M - 500M
  • 500 - 1,000
    - -
  • $100M - 500M
  • 72/100
  • 500 - 1,000
  • - -
  • $100M - 500M
View ProfileView
3
Novus Biologicals's Competitor - Stressmarq Biosciences logo

Ariel Louwrier

President & CEO

84/100
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • 84/100
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
4
Novus Biologicals's Competitor - Bio-Techne logo

Kim Kelderman

President & CEO

82/100
3,000
- -
$1.2B
  • - -
    $1.2B
  • 3,000
    - -
  • $1.2B
  • 82/100
  • 3,000
  • - -
  • $1.2B
View ProfileView
5
Novus Biologicals's Competitor - Abcam logo

Markus B. Lusser

President

82/100
1,000 - 5,000
$156.5M
$100M - 500M
  • $156.5M
    $100M - 500M
  • 1,000 - 5,000
    $156.5M
  • $100M - 500M
  • 82/100
  • 1,000 - 5,000
  • $156.5M
  • $100M - 500M
View ProfileView
Novus Biologicals' top 9 competitors are Tioma Therapeutics, BioLegend, Stressmarq Biosciences, Stratech Scientific, Bio-Techne, Abcam, Anteo Diagnostics, GeneTex and Biological Industries. Together they have raised over 278.2M between their estimated 6.0K employees. Novus Biologicals's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 211.3M. Novus Biologicals has 70 employees and is ranked 7th among it's top 10 competitors. The top 10 competitors average 608.

Novus Biologicals VS Tioma Therapeutics

Tioma Therapeutics is Novus Biologicals's biggest rival. Tioma Therapeutics was founded in Saint Louis, Missouri} in 2006. Like Novus Biologicals, Tioma Therapeutics also competes in the Biotechnology sector. Compared to Novus Biologicals, Tioma Therapeutics generates $7.5M less revenue.

Novus Biologicals VS BioLegend

BioLegend is Novus Biologicals's #2 rival. BioLegend's headquarters is in San Diego, California, and was founded in 2002. Like Novus Biologicals, BioLegend also competes in the Biotechnology space. BioLegend generates 3,166% of Novus Biologicals's revenue.

Looking for similar companies to Novus Biologicals?

Similar Companies

Biotechnology companies in Denver Metropolitan Area

See 208 companies 
Pharmaceuticals & Biotechnology companies in Denver Metropolitan Area

See 302 companies 
Biotechnology companies in Colorado

See 252 companies 
Pharmaceuticals & Biotechnology companies in Colorado

See 367 companies 
Companies in Centennial with revenue in $5.0-25M range

See 1,360 companies 
Companies in Centennial with employees in 25-100 range

See 1,820 companies 
Biotechnology companies with revenue in $5.0-25M range

See 3,620 companies 
Biotechnology companies with employees in 25-100 range

See 5,169 companies 
Pharmaceuticals & Biotechnology companies with revenue in $5.0-25M range

See 5,525 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Novus Biologicals and Novus Biologicals's Competitors

April 24, 2025Benzinga
Thermo Fisher plans $2 billion U.S. investment amid tariff concerns, while analysts lower price targets despite reaffirming positive ratings. Latest Ra...
April 24, 2025PR Newswire
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of cutting-edge life science tools, today announced an Early Access Program fo...
April 24, 2025Marketscreener
CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still wi...
April 25, 2025Investing.com
FDA Asks Novavax to Complete New Study for Delayed Covid-19 Shot's Approval, Sources Say -- WSJ...
April 25, 2025Biospectrum Asia
Thermo Fisher to invest $2 B over next 4 years to enhance innovation in US...
April 24, 2025Endpoints News
Thermo Fisher Scientific has warned it could lose out on nearly $1 billion in revenue this year due to the US-China tariff war and NIH funding cuts. Be...
April 24, 2025Medical Device Network
Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites. The post The...

Frequently Asked Questions about Novus Biologicals

  1. Who are Novus Biologicals's top competitors?

    Novus Biologicals's top 3 competitors are Tioma Therapeutics, BioLegend, Stressmarq Biosciences.

  2. Who is similar to Novus Biologicals?

    Tioma Therapeutics is the most similar to Novus Biologicals. BioLegend and Stressmarq Biosciences are also similar to Novus Biologicals.

  1. Are Novus Biologicals and Tioma Therapeutics competitors?

    Yes, Tioma Therapeutics is one of Novus Biologicals’s top competitors.